Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)

Tundra lists 1 Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06393738

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

This clinical trial is studying the safety and potential anti-tumor activity of an investigational drug called ARV-393 in patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma (R/R NHL) to determine if ARV-393 may be a possible treatment option. ARV-393 is thought to work by breaking down a protein present in many types of non-Hodgkins lymphomas, which may prevent, slow or stop tumor growth. This is the first time ARV-393 will be used by people. The investigational drug will be given as an oral tablet.

Gender: All

Ages: 18 Years - Any

Updated: 2026-02-10

11 states

Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)

Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)